Thymalin
A thymic peptide extract studied by Russian gerontologist Vladimir Khavinson for over 30 years. Thymalin aims to restore thymic function and slow immune aging — with some provocative longevity data from long-term Russian studies.
Thymalin is a peptide bioregulator extracted from calf thymus glands, developed by Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. In long-term Russian studies spanning decades, it showed reduced mortality and improved immune markers in elderly subjects. Western replication of these findings is lacking.
Who's interested: Longevity enthusiasts interested in immune rejuvenation and the Khavinson peptide bioregulator approach. Those who follow Russian gerontology research.
Dive deeper into the researchPotential side effects
- Injection site pain (IM injections are more uncomfortable than SC)
- Mild flu-like symptoms during initial immune activation
- Very limited safety data outside Russian literature
What does Thymalin do?
Your thymus gland is where T-cells — the soldiers of your immune system — are trained and matured. The thymus begins shrinking after puberty and is largely replaced by fat tissue by middle age. This thymic involution is considered a major driver of immune aging.
Thymalin contains peptide fractions extracted from animal thymus tissue, intended to support the remaining thymic function and promote T-cell maturation. The hypothesis: by providing thymic peptides externally, you can partially compensate for the shrinking thymus.
Who uses it?
- Anti-aging protocols — those following Khavinson's peptide bioregulator approach
- Immune rejuvenation — elderly individuals wanting to restore immune competence
- Post-illness recovery — supporting immune reconstruction after chemotherapy or severe illness
What to know before trying
Thymalin's evidence comes primarily from Russian studies spanning 20+ years. These studies report impressive results (reduced mortality, improved biomarkers) but have not been replicated in Western peer-reviewed journals. Evaluate accordingly.
- Short course protocol — typically 10 mg IM daily for 5–10 days, repeated 1–2x per year
- Animal-derived — extracted from calf thymus; synthetic alternatives exist but are less studied
- Different from Thymosin Alpha-1 — Thymalin is a tissue extract containing multiple peptides; TA-1 is a single defined peptide
- Khavinson context — Vladimir Khavinson has developed a whole system of "peptide bioregulators" for different organs; Thymalin is the thymus-specific one
Tracking a peptide protocol?
eterni connects your labs, supplements, and retests — so you can see whether your protocol is actually working.
Get early accessFrequently Asked Questions
What is Thymalin and how is it different from Thymosin Alpha-1?
Thymalin is a peptide extract from calf thymus tissue containing multiple thymic peptide fractions. Thymosin Alpha-1 (TA-1) is a single, defined 28-amino-acid peptide that is synthetically produced. TA-1 has more Western clinical data and is approved as a drug in 35+ countries. Thymalin has primarily Russian clinical data.
What are the Khavinson longevity studies?
Vladimir Khavinson conducted long-term studies (15–20 years) in elderly subjects given thymalin and epithalon (pineal peptide) courses 1–2 times per year. Published results showed reduced mortality, improved immune markers, and better organ function. These studies are notable but have not been independently replicated outside Russia.
Is Thymalin available in India?
Thymalin is available from some peptide vendors and Russian pharmaceutical importers. Quality and authenticity verification can be challenging. It is not approved as a drug in India.
How often do you take Thymalin?
The standard Khavinson protocol is 10 mg intramuscularly daily for 5–10 consecutive days, repeated once or twice per year. This pulsed approach differs from continuous-use peptides.
How it works
- Thymic peptide supply — provides peptide fractions that support T-cell maturation and differentiation
- Immune reconstitution — aims to compensate for declining thymic output with age
- T-cell balance — may help restore the CD4/CD8 ratio that shifts with aging
- Bioregulator concept — Khavinson's theory is that tissue-specific peptides regulate gene expression in their target organs
The Khavinson studies
- 15-year elderly cohort: Combined thymalin + epithalon courses showed 28% mortality reduction vs control
- Immune markers: Improved T-cell counts, normalised cytokine profiles in treated elderly
- Functional improvements: Better physical performance, fewer infections, improved cardiovascular markers
- Limitations: Not double-blinded by Western standards, published primarily in Russian journals
Side effects & safety
- Injection site pain — IM injections are more uncomfortable than subcutaneous
- Flu-like symptoms — mild immune activation symptoms possible in first 1–2 days
- Allergic potential — animal-derived product; allergic reactions possible though rarely reported
- Autoimmune caution — immune modulation could theoretically affect autoimmune conditions
Who should avoid it: People with autoimmune conditions, those allergic to animal-derived products, pregnant or breastfeeding women.
Know what's working. Know what's not.
eterni connects your lab results, supplements, and retests — so you can see the trajectory, not just a snapshot.
Join the waitlist